Physician
Aziz, Kusai
Aziz, Kusai was paid $649K by Medicaid between Jan 2018 and May 2024, across 19 billing codes. Its largest line is 93306, Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete — 31% of everything it billed.
33Billing provider infoAZIZ, KUSAI
VISALIA, CA 93277
VISALIA, CA 93277
33aNPI1265590863assigned 12/05/2006
33bProvider typeCardiovascular Disease Physician
28Total paid$649K
24GClaims21,205
24DCodes billed19
24AFirst – last monthJan 2018 – May 2024
Compared with peers
Next to other Cardiovascular Disease Physician providers in California
Rank by total paid#105 of 714
Median peer was paid$28K
This provider vs. median23×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 215 | $0.00 | |
| 2019 | 4,272 | $213K | |
| 2020 | 5,851 | $294K | |
| 2021 | 2,645 | $73K | |
| 2022 | 1,098 | $10K | |
| 2023 | 5,225 | $44K | |
| 2024incomplete | 1,899 | $16K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | 31% | 2,576 | 2,551 | $203K |
| 78452 | Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress | 14% | 1,468 | 1,401 | $93K |
| 93015 | 12% | 1,788 | 1,703 | $81K | |
| A9500 | Technetium tc-99m sestamibi, diagnostic, per study dose | 9.8% | 1,480 | 1,414 | $64K |
| J7050 | Infusion, normal saline solution, 250 cc | 5.6% | 1,680 | 1,636 | $36K |
| 93000 | 4.9% | 3,299 | 3,252 | $32K | |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 4.7% | 2,686 | 2,578 | $31K |
| J0153 | Injection, adenosine, 1 mg (not to be used to report any adenosine phosphate compounds) | 4.5% | 543 | 530 | $29K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 3.6% | 2,942 | 2,801 | $23K |
| 93224 | 2.5% | 346 | 346 | $16K | |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 2.2% | 662 | 662 | $15K |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 1.5% | 851 | 850 | $10K |
7 more codes
| 93880 | 1.3% | 114 | $9K | |
| 78492 | <1% | 29 | $4K | |
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 384 | $2K |
| J2785 | Injection, regadenoson, 0.1 mg | <1% | 303 | $2K |
| A9555 | Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries | <1% | 29 | $359.66 |
| 93925 | <1% | 12 | $325.52 | |
| 99205 | Prolong outpt/office vis | <1% | 13 | $222.80 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.